Correlation Between Johnson Johnson and Molecular Partners
Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and Molecular Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and Molecular Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Johnson Johnson and Molecular Partners AG, you can compare the effects of market volatilities on Johnson Johnson and Molecular Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of Molecular Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and Molecular Partners.
Diversification Opportunities for Johnson Johnson and Molecular Partners
-0.31 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Johnson and Molecular is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and Molecular Partners AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Partners and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with Molecular Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Partners has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and Molecular Partners go up and down completely randomly.
Pair Corralation between Johnson Johnson and Molecular Partners
Considering the 90-day investment horizon Johnson Johnson is expected to under-perform the Molecular Partners. But the stock apears to be less risky and, when comparing its historical volatility, Johnson Johnson is 4.83 times less risky than Molecular Partners. The stock trades about -0.15 of its potential returns per unit of risk. The Molecular Partners AG is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 525.00 in Molecular Partners AG on September 15, 2024 and sell it today you would earn a total of 30.00 from holding Molecular Partners AG or generate 5.71% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Johnson Johnson vs. Molecular Partners AG
Performance |
Timeline |
Johnson Johnson |
Molecular Partners |
Johnson Johnson and Molecular Partners Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Johnson Johnson and Molecular Partners
The main advantage of trading using opposite Johnson Johnson and Molecular Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, Molecular Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Partners will offset losses from the drop in Molecular Partners' long position.Johnson Johnson vs. Emergent Biosolutions | Johnson Johnson vs. Bausch Health Companies | Johnson Johnson vs. Neurocrine Biosciences | Johnson Johnson vs. Teva Pharma Industries |
Molecular Partners vs. Puma Biotechnology | Molecular Partners vs. Iovance Biotherapeutics | Molecular Partners vs. Day One Biopharmaceuticals | Molecular Partners vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |